ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment.

Mark Roschewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.